Stem cells in regenerative medicine

science, regulation and business strategies

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today


Buy this book

Last edited by ImportBot
February 3, 2023 | History

Stem cells in regenerative medicine

science, regulation and business strategies

This edition doesn't have a description yet. Can you add one?

Publish Date
Language
English

Buy this book

Previews available in: English

Edition Availability
Cover of: Stem Cells in Regenerative Medicine
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
2016, Wiley & Sons, Limited, John
in English
Cover of: Stem Cells in Regenerative Medicine
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
2015, Wiley & Sons, Incorporated, John
in English
Cover of: Stem Cells in Regenerative Medicine
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
2015, Wiley & Sons, Incorporated, John
in English
Cover of: Stem cells in regenerative medicine
Stem cells in regenerative medicine: science, regulation and business strategies
2015, John Wiley & Sons, Ltd
in English
Cover of: Stem Cells in Regenerative Medicine
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
2015, Wiley & Sons, Incorporated, John
in English

Add another edition?

Book Details


Table of Contents

Therapeutic stem cells answer a strategic breakthrough need of healthcare / Alain Vertes
Ethical considerations on the research and business of stem cells / Ljiljana Minwalla
Projected growth of the worldwide stem cell market / Ed Field
Cell therapy manufacturing: identifying and meeting demand / Jessica Carmen, David A. Brindley, Natasha L. Davie and David Smith
The history of stem cell transplantation / Hilliard M. Lazarus and Stan Gerson
Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a U.S. perspective / Michael Mendicino and Darin Weber
The regulation of stem cells in the UK and EU / Alex Denoon, Julian Hitchcock and James Lawford Davies
The business of stem cell research tools / Erik Miljan
Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications / Kate Camerona, Howard Marriage, David Haya and Claire Medine
Stem cell tools for compound development / Tom Novak
Stem cell origin of cancer: prospects for functional therapeutics and regenerative medicine / Vinagolu K. Rajasekhar
The market of stem cell medicines for domestic and high value animals / Bob J. Harmann
Stem cells veterinary medicines: a conceptual approach / John Peroni and Lindsey Boone
Stem cells in veterinary medicines: a practical approach / Bob J. Harmann
Stem cell veterinary medicines as success signals towards human stem cell therapeutics / Alain Vertes
Animal models in regenerative medicine / Andrew N. Bubak, John D. Elsworth and John R. Sladek, Jr.
Stem cell characterization: a guide to stem cell types, technologies, and future applications / Justin Lo Re, Rezma Shrestha and Leonard Sciorra
Stem cell value chains / Judy Muller-Cohn, Paul Diaz and Rolf Muller
Stem cell culture processes / Ravali Raju, Shikha Sharma and Wei-Shou Hu
Indication transformation maps and the challenge of live cells delivery / Bob Deans and Lee Babiss
Delivery and targeting of therapeutic cells / Paul Lin, Arnold I. Caplan and Erkki Ruoshlati
Hematopoietic stem cells / Steve Wolpe and Lynnet Koh
MSCs: the new medicince / Arnold Caplan
Innovation and commercialization of induced pluripotent stem cells / Shintaro Sengoku
Embryonic stem cells / Rachel Eiges, Benjamin E. Reubinoff and Charles Irving
Allogeneic versus autologous stem cell transplantation in regenerative medicine / Kathy Trzaska-Accurso and Pranela Rameshwar
Clinical immunological barriers to regenerative medicine: do they matter? / Cristina Trento and Francesco Dazzi
Challenges in the clinical development of stem cells / John Caulfield
Pricing and reimbursement of regenerative medicines / Nathan Dowden
The role of patient advocacy in the clinical translation of regenerative medicine / Bernard Siegel and Alan Jakimo
Financing strategies for regenerative medicine start-ups / Carol Julie Walton, Lee Buckler and Gregory A. Bonfiglio
Strategic alliances, mergers and acquisitions in regenerative medicine / Nafees N. Malik, Timothy E. Allsopp and Devyn M. Smith
History of monoclonal antibodies and lessons for the development of stem cell therapeutics / Alain Vertes and Nathan Dowden
Deployment of stem cell technologies in industry and healthcare/ Alain Vertes.

Edition Notes

Includes bibliographical references and index.

Published in
Hoboken, NJ

Classifications

Dewey Decimal Class
616.02/774
Library of Congress
QH588.S83 S7473 2015, QH588.S83S7473 2015

The Physical Object

Pagination
pages cm

ID Numbers

Open Library
OL30392729M
Internet Archive
isbn_9781119971399
ISBN 13
9781119971399
LCCN
2015007931
OCLC/WorldCat
898924079

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
February 3, 2023 Edited by ImportBot import existing book
September 21, 2020 Edited by MARC Bot import existing book
August 24, 2020 Created by ImportBot import new book